You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》樂普醫療(300003.SZ)附屬心泰醫療向聯交所提交上市申請
樂普醫療(300003.SZ)公布,控股子公司樂普心泰醫療科技(上海)股份已於上周五(25日)向香港聯交所遞交首次公開發行境外上市外資股(H股)並在香港聯交所主板上市的申請。獨家保薦人為中金公司。

公司表示,心泰醫療本次境外上市事項尚需取得中國證監會、香港證監會及香港聯交所及相關監管機構的核准(或批准),仍存在不確定性。

初步招股文件顯示,心泰醫療主要從事結構性心臟病介入醫療器械的研發、生產及商業化,擁有15種已上市封堵器產品、14種封堵器在研產品及19種心臟瓣膜在研產品,於去年度錄得利潤6,877.2萬元人民幣,按年升32.5%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account